Moreover, the serum levels of IL-32 correlated with mean pulmonary arterial pressure and systolic pulmonary arterial pressure indicating that IL-32 could be used as a new screening tool for PAH in patients with SSc (16). This evidence concerns the gene IL32 and systemic sclerosis.